Literature DB >> 15084509

Intraspecific diversity of Yersinia pestis.

Andrey P Anisimov1, Luther E Lindler, Gerald B Pier.   

Abstract

Increased interest in the pathogenic potential of Yersinia pestis has emerged because of the potential threats from bioterrorism. Pathogenic potential is based on genetic factors present in a population of microbes, yet most studies evaluating the role of specific genes in virulence have used a limited number of strains. For Y. pestis this issue is complicated by the fact that most strains available for study in the Americas are clonally derived and thus genetically restricted, emanating from a strain of Y. pestis introduced into the United States in 1902 via marine shipping and subsequent spread of this strain throughout North and South America. In countries from the former Soviet Union (FSU), Mongolia, and China there are large areas of enzootic foci of Y. pestis infection containing genetically diverse strains that have been intensely studied by scientists in these countries. However, the results of these investigations are not generally known outside of these countries. Here we describe the variety of methods used in the FSU to classify Y. pestis strains based on genetic and phenotypic variation and show that there is a high level of diversity in these strains not reflected by ones obtained from sylvatic areas and patients in the Americas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084509      PMCID: PMC387406          DOI: 10.1128/CMR.17.2.434-464.2004

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  126 in total

1.  Determination of genome size, macrorestriction pattern polymorphism, and nonpigmentation-specific deletion in Yersinia pestis by pulsed-field gel electrophoresis.

Authors:  T S Lucier; R R Brubaker
Journal:  J Bacteriol       Date:  1992-04       Impact factor: 3.490

Review 2.  Common themes in microbial pathogenicity revisited.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

Review 3.  Cases of cat-associated human plague in the Western US, 1977-1998.

Authors:  K L Gage; D T Dennis; K A Orloski; P Ettestad; T L Brown; P J Reynolds; W J Pape; C L Fritz; L G Carter; J D Stein
Journal:  Clin Infect Dis       Date:  2000-06-13       Impact factor: 9.079

Review 4.  Plague immunization. I. Past and present trends.

Authors:  K F Meyer; D C Cavanaugh; P J Bartelloni; J D Marshall
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

Review 5.  How bacteria resist killing by host-defense peptides.

Authors:  E A Groisman
Journal:  Trends Microbiol       Date:  1994-11       Impact factor: 17.079

6.  [Low-molecular plasmids--a prospective test for the intraspecific differentiation of Yersinia pestis].

Authors:  L I Gramotina; S L Protsenko
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  1994 Nov-Dec

7.  Essential virulence determinants of different Yersinia species are carried on a common plasmid.

Authors:  R Ben-Gurion; A Shafferman
Journal:  Plasmid       Date:  1981-03       Impact factor: 3.466

8.  Virulence of pPst+ and pPst- strains of Yersinia pestis for guinea-pigs.

Authors:  S V Samoilova; L V Samoilova; I N Yezhov; I G Drozdov; A P Anisimov
Journal:  J Med Microbiol       Date:  1996-12       Impact factor: 2.472

9.  [Cefoperazone in the prevention and treatment of experimental plague caused by typical and fraction-free pathogen strains in white mice].

Authors:  V V Pasiukov; I V Ryzhko; R I Tsuraeva; E D Samokhodkina; N V Roshchina
Journal:  Antibiot Khimioter       Date:  1994-08

10.  Potential for rat plague from nonencapsulated variants of the plague bacillus (Yersinia pestis).

Authors:  J E Williams; D C Cavanaugh
Journal:  Experientia       Date:  1984-07-15
View more
  114 in total

1.  Population structure of the Yersinia pseudotuberculosis complex according to multilocus sequence typing.

Authors:  Riikka Laukkanen-Ninios; Xavier Didelot; Keith A Jolley; Giovanna Morelli; Vartul Sangal; Paula Kristo; Carina Brehony; Priscilla F M Imori; Hiroshi Fukushima; Anja Siitonen; Galina Tseneva; Ekaterina Voskressenskaya; Juliana P Falcao; Hannu Korkeala; Martin C J Maiden; Camila Mazzoni; Elisabeth Carniel; Mikael Skurnik; Mark Achtman
Journal:  Environ Microbiol       Date:  2011-09-27       Impact factor: 5.491

Review 2.  An additional step in the transmission of Yersinia pestis?

Authors:  W Ryan Easterday; Kyrre L Kausrud; Bastiaan Star; Lise Heier; Bradd J Haley; Vladimir Ageyev; Rita R Colwell; Nils Chr Stenseth
Journal:  ISME J       Date:  2011-08-11       Impact factor: 10.302

3.  Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.

Authors:  Alexander V Philipovskiy; Stephen T Smiley
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

4.  Proteomic characterization of Yersinia pestis virulence.

Authors:  Brett A Chromy; Megan W Choi; Gloria A Murphy; Arlene D Gonzales; Chris H Corzett; Brian C Chang; J Patrick Fitch; Sandra L McCutchen-Maloney
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

Review 5.  Insights from genomic comparisons of genetically monomorphic bacterial pathogens.

Authors:  Mark Achtman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

6.  Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis.

Authors:  Debaditya Bhattacharya; Joan Mecsas; Linden T Hu
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

7.  A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.

Authors:  Hitoki Yamanaka; Teri Hoyt; Xinghong Yang; Sarah Golden; Catharine M Bosio; Kathryn Crist; Todd Becker; Massimo Maddaloni; David W Pascual
Journal:  Infect Immun       Date:  2008-08-11       Impact factor: 3.441

8.  Yersinia pestis IS1541 transposition provides for escape from plague immunity.

Authors:  Claire A Cornelius; Lauriane E Quenee; Derek Elli; Nancy A Ciletti; Olaf Schneewind
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

9.  An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague.

Authors:  Hitoki Yamanaka; Teri Hoyt; Richard Bowen; Xinghong Yang; Kathryn Crist; Sarah Golden; Massimo Maddaloni; David W Pascual
Journal:  Vaccine       Date:  2008-10-26       Impact factor: 3.641

10.  Structural organization of the pFra virulence-associated plasmid of rhamnose-positive Yersinia pestis.

Authors:  Andrey Golubov; Heinrich Neubauer; Christina Nölting; Jürgen Heesemann; Alexander Rakin
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.